Novo Nordisk's oral semaglutide (Ozempic/Wegovy ingredient) failed to slow Alzheimer's disease in trials with 3,800+ patients. Though safe, it didn't prevent cognitive decline versus placebo. #SemaglutideAlzheimersDisease www.drugs.com/news/pill-se...
Pill Form of Semaglutide Fails to Slow Alzheimer's in Large Trial - Drugs.com MedNews
TUESDAY, Nov. 25, 2025 A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer s disease, drugmaker Novo Nor
www.drugs.com
November 25, 2025 at 6:15 PM
Novo Nordisk's oral semaglutide (Ozempic/Wegovy ingredient) failed to slow Alzheimer's disease in trials with 3,800+ patients. Though safe, it didn't prevent cognitive decline versus placebo. #SemaglutideAlzheimersDisease www.drugs.com/news/pill-se...